| Targeting apoptosis in cancer therapy BA Carneiro, WS El-Deiry Nature reviews Clinical oncology 17 (7), 395-417, 2020 | 1640 | 2020 |
| Wnt/beta-catenin pathway: modulating anticancer immune response SG Pai, BA Carneiro, JM Mota, R Costa, CA Leite, R Barroso-Sousa, ... Journal of hematology & oncology 10, 1-12, 2017 | 596 | 2017 |
| Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ... The Lancet Oncology 22 (7), 931-945, 2021 | 446 | 2021 |
| Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application YK Chae, K Ranganath, PS Hammerman, C Vaklavas, N Mohindra, ... Oncotarget 8 (9), 16052, 2017 | 313 | 2017 |
| Repurposing metformin for cancer treatment: current clinical studies YK Chae, A Arya, MK Malecek, DS Shin, B Carneiro, S Chandra, J Kaplan, ... Oncotarget 7 (26), 40767, 2016 | 313 | 2016 |
| Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development R Costa, AN Shah, CA Santa-Maria, MR Cruz, D Mahalingam, ... Cancer treatment reviews 53, 111-119, 2017 | 189 | 2017 |
| Cholera, diarrhea, and oral rehydration therapy: triumph and indictment RL Guerrant, BA Carneiro-Filho, RA Dillingham Clinical Infectious Diseases 37 (3), 398-405, 2003 | 177 | 2003 |
| Emerging therapeutic targets in bladder cancer BA Carneiro, JJ Meeks, TM Kuzel, M Scaranti, SA Abdulkadir, FJ Giles Cancer Treatment Reviews 41 (2), 170-178, 2015 | 175 | 2015 |
| Genomic landscape of DNA repair genes in cancer YK Chae, JF Anker, BA Carneiro, S Chandra, J Kaplan, A Kalyan, ... Oncotarget 7 (17), 23312, 2016 | 172 | 2016 |
| Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis S Chuzi, F Tavora, M Cruz, R Costa, YK Chae, BA Carneiro, FJ Giles Cancer management and research, 207-213, 2017 | 158 | 2017 |
| Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study NM Chanzá, W Xie, MA Bilen, H Dzimitrowicz, J Burkart, DM Geynisman, ... The lancet oncology 20 (4), 581-590, 2019 | 155 | 2019 |
| Mechanism of Clostridium difficile Toxin A–Induced Apoptosis in T84 Cells GAC Brito, J Fujji, BA Carneiro-Filho, AAM Lima, T Obrig, RL Guerrant The Journal of infectious diseases 186 (10), 1438-1447, 2002 | 152 | 2002 |
| Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling YK Chae, SY Chung, AA Davis, BA Carneiro, S Chandra, J Kaplan, ... Oncotarget 6 (35), 37117, 2015 | 146 | 2015 |
| Molecular pathways: revisiting glycogen synthase kinase-3β as a target for the treatment of cancer A Walz, A Ugolkov, S Chandra, A Kozikowski, BA Carneiro, TV O'Halloran, ... Clinical Cancer Research 23 (8), 1891-1897, 2017 | 144 | 2017 |
| Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis BA Carneiro-Filho, IPF Lima, DH Araujo, MC Cavalcante, GHP Carvalho, ... Digestive diseases and sciences 49, 65-72, 2004 | 142 | 2004 |
| Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials R Costa, BA Carneiro, M Agulnik, AW Rademaker, SG Pai, VM Villaflor, ... Oncotarget 8 (5), 8910, 2017 | 134 | 2017 |
| ONC201 and imipridones: Anti-cancer compounds with clinical efficacy VV Prabhu, S Morrow, AR Kawakibi, L Zhou, M Ralff, J Ray, A Jhaveri, ... Neoplasia 22 (12), 725-744, 2020 | 120 | 2020 |
| FGFR3-TACC3 fusion in solid tumors: mini review R Costa, BA Carneiro, T Taxter, FA Tavora, A Kalyan, SA Pai, YK Chae, ... Oncotarget 7 (34), 55924, 2016 | 118 | 2016 |
| Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA YK Chae, AA Davis, BA Carneiro, S Chandra, N Mohindra, A Kalyan, ... Oncotarget 7 (40), 65364, 2016 | 116 | 2016 |
| Nivolumab in metastatic adrenocortical carcinoma: results of a phase 2 trial BA Carneiro, B Konda, RB Costa, RLB Costa, V Sagar, DB Gursel, ... The Journal of Clinical Endocrinology & Metabolism 104 (12), 6193-6200, 2019 | 113 | 2019 |
